US Patent 11034670 Poly-ADP ribose polymerase (PARP) inhibitors
Patent 11034670 was granted and assigned to Mitobridge on June, 2021 by the United States Patent and Trademark Office.
All edits
Edits on 30 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 12 Dec, 2023
Golden AI
Edits made to:
Article (+203 characters)
Article
Patent abstract
The present invention is related to a pharmaceutical composition comprising a pharmaceutically acceptable carrier or diluent and a compound represented by the following structural formula:
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 24 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110346700
Date of Patent
June 15, 2021
0Patent Application Number
164731270
Date Filed
December 28, 2017
0Official Website
Patent Primary Examiner
Edits on 22 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
110346700
Date of Patent
June 15, 2021
0Patent Application Number
164731270
Date Filed
December 28, 2017
0Official Website
Patent Primary Examiner
Edits on 6 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 12 Feb, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 11034670 Poly-ADP ribose polymerase (PARP) inhibitors
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11034670
Date of patent
June 15, 2021
Patent application number
16473127
Date Filed
December 28, 2017
Patent primary examiner
Find more entities like US Patent 11034670 Poly-ADP ribose polymerase (PARP) inhibitors
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
